Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization (Q36407800)

14 August 2017

1 reference

title

Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization (English)

1 reference

14 August 2017

0 references

0 references

0 references

Zhou Xing

1

1 reference

PubMed ID

16504584

14 August 2017

Brian D Lichty

series ordinal

2

1 reference

14 August 2017

28 February 2006

1 reference

14 August 2017

1 reference

14 August 2017

86

1 reference

14 August 2017

3-4

1 reference

14 August 2017

211-217

1 reference

Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

TB vaccines for the World

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Tuberculosis vaccines: the past, present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Tuberculosis vaccine development: research, regulatory and clinical strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Adenoviral vectors for mucosal vaccination against infectious diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

TB vaccines: progress and problems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

The use of adenoviral vectors for gene therapy and gene transfer in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Gene therapy progress and prospects: adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Gene transfer for cytokine functional studies in the lung: the multifunctional role of GM-CSF in pulmonary inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Adenoviruses as vaccine vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Compartmentalized transgene expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) in mouse lung enhances allergic airways inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Detailed analysis of the CD8+ T-cell response following adenovirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Vesicular stomatitis virus: re-inventing the bullet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Multiple vesiculoviral matrix proteins inhibit both nuclear export and import

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Recombinant vesicular stomatitis viruses from DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TUBE.2006.01.017

1 reference

14 August 2017

1 reference

PubMed ID

16504584